In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of SeaStar Medical Holding Corp (NASDAQ: ICU) was $0.61 for the day, down -50.94% from the previous closing price of $1.24. In other words, the price has decreased by -$50.94 from its previous closing price. On the day, 24.48 million shares were traded. ICU stock price reached its highest trading level at $0.6688 during the session, while it also had its lowest trading level at $0.54.
Ratios:
Our analysis of ICU’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 26 ’25 when Van Heel Kenneth bought 25,000 shares for $0.89 per share. The transaction valued at 22,248 led to the insider holds 39,400 shares of the business.
Van Heel Kenneth bought 10,000 shares of ICU for $8,565 on Aug 27 ’25. The Director now owns 49,400 shares after completing the transaction at $0.86 per share. On Aug 22 ’25, another insider, Chung Kevin, who serves as the Chief Medical Officer of the company, bought 10,000 shares for $0.80 each. As a result, the insider paid 8,000 and bolstered with 58,184 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICU now has a Market Capitalization of 34614100 and an Enterprise Value of 10678449. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.05 while its Price-to-Book (P/B) ratio in mrq is 3.16. Its current Enterprise Value per Revenue stands at 13.941.
Stock Price History:
The Beta on a monthly basis for ICU is -0.91, which has changed by -0.8579439 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, ICU has reached a high of $4.85, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is -25.68%, while the 200-Day Moving Average is calculated to be -54.34%.
Shares Statistics:
ICU traded an average of 7.60M shares per day over the past three months and 4594700 shares per day over the past ten days. A total of 27.91M shares are outstanding, with a floating share count of 27.57M. Insiders hold about 1.25% of the company’s shares, while institutions hold 1.73% stake in the company. Shares short for ICU as of 1756425600 were 3128638 with a Short Ratio of 0.59, compared to 1753920000 on 2071239. Therefore, it implies a Short% of Shares Outstanding of 3128638 and a Short% of Float of 11.26.
Earnings Estimates
The stock of SeaStar Medical Holding Corp (ICU) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.13 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.72 and -$0.72 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.45, with 1.0 analysts recommending between -$0.45 and -$0.45.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $250k to a low estimate of $250k. As of the current estimate, SeaStar Medical Holding Corp’s year-ago sales were $68kFor the next quarter, 1 analysts are estimating revenue of $350k. There is a high estimate of $350k for the next quarter, whereas the lowest estimate is $350k.
A total of 1 analysts have provided revenue estimates for ICU’s current fiscal year. The highest revenue estimate was $1.23M, while the lowest revenue estimate was $1.23M, resulting in an average revenue estimate of $1.23M. In the same quarter a year ago, actual revenue was $135kBased on 1 analysts’ estimates, the company’s revenue will be $2.01M in the next fiscal year. The high estimate is $2.01M and the low estimate is $2.01M.
